NCT04624867View on ClinicalTrials.gov

Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch

PHASE1UnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Cumulative Irritation and Sensitization
Interventions
DRUG

HP-1050 Patch

Both articles, HP-1050 and XULANE patch, will be applied simultaneously on the back of each subject.

Trial Locations (1)

65802

RECRUITING

QPS Missouri, Springfield

Sponsors
All Listed Sponsors
lead

Noven Pharmaceuticals, Inc.

INDUSTRY

NCT04624867 - Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch | Biotech Hunter | Biotech Hunter